Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of chondroitin sulfate nano selenium in preparing medicine for treating nervous system diseases related to cognitive function decline

A technology for nervous system diseases and chondroitin sulfate, which is applied in the field of medicine, can solve the problems of high toxicity and poisoning of inorganic selenium, and achieve good protective effects, inhibition of aggregation, and low cytotoxicity

Inactive Publication Date: 2019-11-08
SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, inorganic selenium is highly toxic, and the safe dose is 400 μg / day, and the effective dose of inorganic selenium-containing substances is not much different from the toxic dose, and overdose can cause poisoning

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of chondroitin sulfate nano selenium in preparing medicine for treating nervous system diseases related to cognitive function decline
  • Application of chondroitin sulfate nano selenium in preparing medicine for treating nervous system diseases related to cognitive function decline
  • Application of chondroitin sulfate nano selenium in preparing medicine for treating nervous system diseases related to cognitive function decline

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] The preparation of embodiment 1 chondroitin sulfate nano selenium

[0023] Take 100mmol Na 2 SeO 3 , 200mmol shark CS (Na 2 SeO 3 : CS molar ratio=1:2) was dissolved in 80ml deionized water, and 50mM L-cysteine ​​(L-cys) solution (Na 2 SeO 3 :L-cys molar ratio=1:2), magnetic stirring at 30°C for 1.5h. After the MWCO 1000 dialysis bag was dialyzed against water for 48 hours (change the water every 2 hours), it was freeze-dried to obtain pink chondroitin sulfate nano-selenium.

Embodiment 2

[0024] Example 2 Effect of CS@Se on the structure of Aβ fibrils

[0025] Take 1mg Aβ 1-42 Dissolve in 2.216mL sterile water and filter through a 0.22μm microporous membrane to obtain a 100μM Aβ solution for later use. Take the Aβ solution and add the final concentration of CS@Se (25 μg / mL and 50 μg / mL), CS (48.55 μg / mL), nano-Se (1.45 μg / mL) solution, and the blank control group is 100 μM Aβ 1-42 . Then incubate the sample at 37°C for 3 days, take the sample for electron microscope observation experiment, drop the sample onto a 200-mesh Formvar-coated copper grid, dry at 25°C for 1min, and negatively stain with 2% phosphotungstic acid, Aβ 1～42 Fibril morphology JEM-1400 transmission electron microscope was used to observe the effect of CS@Se on the formation of Aβ fibril structure. The result is as figure 1 As shown, the inhibitory effect of CS@Se on the ultrastructure of Aβ fibers was observed by transmission electron microscope, Aβ 1-42 Samples incubated without CS@Se f...

Embodiment 3

[0026] Example 3 CS@Se to Aβ 1-42 inhibition of aggregation

[0027] To characterize the effect of CS@Se on Aβ 1-42 Inhibition of Aggregation Using a ThT Fluorescent Dye with Aβ 1-42 Fibrillar structure-specific binding characteristics examined for Aβ 1-42 polymerization kinetics. Aβ 1-42 The solution (100 μM) was incubated with CS@Se (25 μg / mL and 50 μg / mL), CS (48.55 μg / mL), nano-Se (1.45 μg / mL) at 37 °C in the dark for 72 h, at different time points ( 0h, 10h, 24h, 48h, 72h, 100h) take out 30μL Aβ 1-42 The solution was mixed with 400 uL ThT (15 μM) solution, incubated at room temperature in the dark for 30 min, and then the fluorescence intensity was measured by a fluorescence spectrophotometer. The excitation wavelength is 440nm, the emission wavelength is 480nm, and the slit width is 20nm. The result is as figure 2As shown, when Aβ 1-42 After incubation for 72h, Aβ 1-42 The kinetic growth curves of β-β were semi-S-shaped, which was consistent with the research ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of chondroitin sulfate nano selenium in preparing a medicine for treating nervous system diseases related to cognitive function decline, and combines the advantages of chondroitin sulfate and nano selenium. The prepared chondroitin sulfate nano selenium effectively reduces the toxicity of inorganic selenium, has multiple pharmacological activities of inhibiting A beta aggregation, relieving oxidative stress reaction and the like, and can be used for preparing a medicine for treating nervous system diseases related to cognitive function decline.

Description

technical field [0001] The invention relates to the application of chondroitin sulfate nano-selenium in the preparation of medicines for treating neurological diseases related to cognitive function decline. It belongs to the field of medical technology. Background technique [0002] Chondroitin sulfate (CS) is a sulfated glycosaminoglycan present in the extracellular matrix. CS has various biological activities, such as anti-inflammatory, anti-oxidative, neuroprotective and anti-neuroinflammation etc. CS is usually attached to the protein core to form chondroitin sulfate proteoglycan (CSPG). CSPGs are mainly distributed in the matrix around neurons and participate in neurogenesis, migration, axon growth and guidance, synaptic plasticity and regeneration after nervous system injury. CS protects SH-SY5Y cells under oxidative stress by activating protein kinase C (PKC), reducing the formation of reactive oxygen species. CS can also inhibit Aβ fibril formation, block Aβ-indu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K33/04A61K31/737A61P25/28
CPCA61K31/737A61K33/04A61P25/28A61K2300/00
Inventor 肖玉良徐巍姬东升高飞刘平李德龙张思涛
Owner SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com